<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-HON-2715</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2715</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>Гиперсегментация ядер нейтрофилов крови у больных с локализованным и распространенным раком гортани и гортаноглотки</article-title><trans-title-group xml:lang="en"><trans-title>Hypersegmentation of neutrophil nuclei in peripheral blood of patients with localized and advanced cancer of the larynx and laryngopharynx</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1639-4676</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кологривова</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kologrivova</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кологривова Елена Николаевна — доктор медицинских наук, профессор, профессор кафедры иммунологии и аллергологии.</p><p>634050, Томск, Московский тракт, 2</p><p>Тел.: 8 (913) 876-80-69</p></bio><bio xml:lang="en"><p>Elena N. Kologrivova - PhD, MD (Medicine), Professor, Department of Immunology and Allergology, Siberian State Medical University.</p><p>2 Moskovsky trakt Tomsk 634050</p><p>Phone: +7 (913) 876-80-69</p></bio><email xlink:type="simple">enkologrivova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6476-9826</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плешко</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pleshko</surname><given-names>R. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Плешко Раиса Ивановна — доктор медицинских наук, профессор, профессор кафедры морфологии и общей патологии.</p><p>Томск</p></bio><bio xml:lang="en"><p>Raisa I. Pleshko - PhD, MD (Medicine), Professor, Department of Morphology and General Pathology, Siberian State Medical University.</p><p>Tomsk</p></bio><email xlink:type="simple">raisap57@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7234-4708</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черемисина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Cheremisina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Черемисина Ольга Владимировна — доктор медицинских наук, заведующая эндоскопическим отделением.</p><p>Томск</p></bio><bio xml:lang="en"><p>Olga V. Cheremisina - PhD, MD (Medicine), Head, Endoscopic Department, Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences.</p><p>Tomsk</p></bio><email xlink:type="simple">cheremisinaov@oncology.tomsk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2399-4170</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болдышевская</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Boldyshevskaya</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Болдышевская Маргарита Андреевна — врач клинической лабораторной диагностики патолого-анатомического отделения.</p><p>Томск</p></bio><bio xml:lang="en"><p>Margarita A. Boldyshevskaya - Doctor of Clinical Laboratory Diagnostics, Pathological and Anatomical Department, Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences.</p><p>Tomsk</p></bio><email xlink:type="simple">afanasyeva97@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Сибирский государственный медицинский университет» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт онкологии ФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2023</year></pub-date><volume>25</volume><issue>5</issue><fpage>1111</fpage><lpage>1116</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кологривова Е.Н., Плешко Р.И., Черемисина О.В., Болдышевская М.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Кологривова Е.Н., Плешко Р.И., Черемисина О.В., Болдышевская М.А.</copyright-holder><copyright-holder xml:lang="en">Kologrivova E.N., Pleshko R.I., Cheremisina O.V., Boldyshevskaya M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2715">https://www.mimmun.ru/mimmun/article/view/2715</self-uri><abstract><p>Нейтрофильные гранулоциты обладают широким спектром функциональной активности. В последние годы обсуждается функциональная значимость нейтрофилов в развитии и течении злокачественных новообразований. Показано, что при опухолевом росте нейтрофильные гранулоциты могут играть двоякую роль, проявляя про- или противоопухолевую активность. Результаты клинических и экспериментальных исследований свидетельствуют о возможности перепрограммирования нейтрофилов под влиянием факторов микроокружения. Цель исследования — оценка структурных и функциональных особенностей нейтрофильных гранулоцитов у больных с разной степенью распространенности рака гортани и гортаноглотки. Проведено обследование 41 пациента (мужчины в возрасте от 35 до 67 лет) с впервые выявленным раком гортани и гортаноглотки. После окончательной верификации диагноза пациенты были разделены на подгруппы в соответствии с классификацией TNM: первую подгруппу с локализованным опухолевым процессом (T1-3N0M0) составили 14 пациентов, вторая подгруппа состояла из 27 пациентов с распространенным опухолевым процессом (T3N1-2M0). В периферической крови оценивали относительное и абсолютное количество нейтрофилов, определяли нейтрофильно-лимфоцитарное соотношение (NLR). Подсчитывали относительное содержание в крови нейтрофилов с разной степенью сегментированности ядер, цитохимически определяли активность кислородозависмых и кислородонезависмых механизмов микробицидности (миелопероксидазы, катионных белков, щелочной фосфатазы и степень активации нейтрофилов в НСТ-тесте). Концентрацию интерлейкина-8 определяли с помощью иммуноферментного анализа. Выявлено, что у больных раком гортани и гортаноглотки на фоне повышенной в сравнении со здоровыми концентрации интерлейкина-8 возрастает численность циркулирующих в крови нейтрофильных гранулоцитов (р = 0,045) и NLR (р = 0,033). В популяции нейтрофилов по мере распространения опухолевого процесса увеличивается доля клеток, обладающих гиперсегментированными ядрами (р &lt; 0,001) и повышенным цитотоксическим потенциалом. Выявлена прямая корреляционная связь средней силы (r = 0,42, p = 0,03) между индексом Т, отражающим объем опухоли, и относительным содержанием гиперсегментированных нейтрофилов. На основании результатов настоящего исследования можно утверждать, что такой простой и доступный для анализа лабораторный параметр, как степень сегментации ядер нейтрофильных гранулоцитов, может быть использован в качестве одного из критериев, позволяющих оценивать и прогнозировать особенности течения опухолевого процесса.</p></abstract><trans-abstract xml:lang="en"><p>Neutrophilic granulocytes have a wide spectrum of functional activity. In recent years, the functional significance of neutrophils in the development and course of malignant neoplasms has been discussed. It has been shown that neutrophilic granulocytes can play pro- or antitumor activity. The aim of the study was to assess the structural and functional features of neutrophils in patients with varying degrees of prevalence of cancer of the larynx and laryngopharynx. Forty-one patients (aged 35-67) with newly diagnosed cancer of the larynx and laryngopharynx were examined and divided into subgroups according to the TNM classification: the first subgroup (14 patients) with a localized tumor process consisted; and the second subgroup (27 patients) with a widespread tumor process. The relative and absolute number of neutrophils was assessed, and the neutrophil-lymphocyte ratio (NLR) was determined. The content of neutrophils with varying degrees of nuclear segmentation in the blood was calculated, the activity of myeloperoxidase, cationic proteins, alkaline phosphatase, and the degree of neutrophil activation in the NBT test was determined cytochemically. Concentration of interleukin-8 was determined using ELISA. In patients with cancer of the larynx and laryngopharynx the number of neutrophils (p = 0.045) and NLR (p = 0.033), as well as serum concentration of interleukin 8 (p = 0.011), increased compared to healthy individuals. The proportion of cells with hypersegmented nuclei in the neutrophil population (p &lt; 0.001) and cytotoxic potential increased with the spread of tumor process. A direct correlation (r = 0.42, p = 0.03) was found between the T index, which reflects the volume of the tumor, and the content of hypersegmented neutrophils. It can be argued that such a simple and accessible laboratory parameter as the degree of segmentation of the nuclei of neutrophilic granulocytes can be used as one of the criteria to assess and predict the course of the tumor process.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак гортани</kwd><kwd>рак гортаноглотки</kwd><kwd>объем опухоли</kwd><kwd>нейтрофилы</kwd><kwd>гиперсегментация ядер</kwd><kwd>цитотоксичность нейтрофилов</kwd><kwd>IL-8</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cancer of the larynx</kwd><kwd>cancer of the laryngopharynx</kwd><kwd>tumor volume</kwd><kwd>neutrophil</kwd><kwd>hypersegmentation of nuclei</kwd><kwd>cytotoxicity of neutrophils</kwd><kwd>IL-8</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fridlender Z.G., Albelda S.M. Tumor-associated neutrophils:friend or foe? Carcinogenesis, 2012, Vol. 33, no. 5, pp. 949-955.</mixed-citation><mixed-citation xml:lang="en">Fridlender Z.G., Albelda S.M. Tumor-associated neutrophils:friend or foe? Carcinogenesis, 2012, Vol. 33, no. 5, pp. 949-955.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Granot Z. Neutrophils as a therapeutic target in cancer. Front. Immunol., 2019, Vol. 10, 1710. doi: 0.3389/fimmu.2019.01710.</mixed-citation><mixed-citation xml:lang="en">Granot Z. Neutrophils as a therapeutic target in cancer. Front. Immunol., 2019, Vol. 10, 1710. doi: 0.3389/fimmu.2019.01710.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Heyhow F.G.J., Kvaglino D. Hematological cytochemistry. Moscow: Moskva, 1983. 230 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Heyhow F.G.J., Kvaglino D. Hematological cytochemistry. Moscow: Moskva, 1983. 230 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lecot P., Sarabi M., Pereira Abrantes M., Mussard J., Koenderman L., Caux C., Bendriss-Vermare N., Michallet M.-C. Neutrophil heterogeneity in cancer: from biology to therapies. Front. Immunol., 2019, Vol. 10, 2155. doi: 10.3389/fimmu.2019.02155.</mixed-citation><mixed-citation xml:lang="en">Lecot P., Sarabi M., Pereira Abrantes M., Mussard J., Koenderman L., Caux C., Bendriss-Vermare N., Michallet M.-C. Neutrophil heterogeneity in cancer: from biology to therapies. Front. Immunol., 2019, Vol. 10, 2155. doi: 10.3389/fimmu.2019.02155.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Manley H.R., Keightley M.C., Lieschke G.J. The neutrophil nucleus: an important influence on neutrophil migration and function. Front. Immunol., 2018, Vol. 9, 2867. doi: 10.3389/fimmu.2018.02867.</mixed-citation><mixed-citation xml:lang="en">Manley H.R., Keightley M.C., Lieschke G.J. The neutrophil nucleus: an important influence on neutrophil migration and function. Front. Immunol., 2018, Vol. 9, 2867. doi: 10.3389/fimmu.2018.02867.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Masucci M.T., Minopoli M., Carriero M.V. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front. Oncol., 2019, Vol. 9, 1146. doi: 10.3389/fonc.2019.01146.</mixed-citation><mixed-citation xml:lang="en">Masucci M.T., Minopoli M., Carriero M.V. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front. Oncol., 2019, Vol. 9, 1146. doi: 10.3389/fonc.2019.01146.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ohms M., Moller S., Laskay T. An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro. Front. Immunol., 2020, Vol. 11, 532. doi: 10.3389/fimmu.2020.00532.</mixed-citation><mixed-citation xml:lang="en">Ohms M., Moller S., Laskay T. An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro. Front. Immunol., 2020, Vol. 11, 532. doi: 10.3389/fimmu.2020.00532.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rosales C. Neutrophil: a cell with many roles in inflammation or several cell types? Front. Physiol., 2018, Vol. 9, 113. doi: 10.3389/fphys.2018.00113.</mixed-citation><mixed-citation xml:lang="en">Rosales C. Neutrophil: a cell with many roles in inflammation or several cell types? Front. Physiol., 2018, Vol. 9, 113. doi: 10.3389/fphys.2018.00113.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Salvermoser M., Begandt D., Alon R., Walzog B. Nuclear deformation during neutrophil migration at sites of inflammation. Front. Immunol., 2018, Vol. 9, 2680. doi: 10.3389/fimmu.2018.02680.</mixed-citation><mixed-citation xml:lang="en">Salvermoser M., Begandt D., Alon R., Walzog B. Nuclear deformation during neutrophil migration at sites of inflammation. Front. Immunol., 2018, Vol. 9, 2680. doi: 10.3389/fimmu.2018.02680.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Shresthaa S., Kima C.-Y., Yuna Y.-J., Kimb J.-K., Leec J.M., Shind M., Songa D.-K., Hongb C.-W. Retinoic acid induces hypersegmentation and enhances cytotoxicityof neutrophils against cancer cells. Immunol. Lett., 2017, Vol. 182, pp. 24-29.</mixed-citation><mixed-citation xml:lang="en">Shresthaa S., Kima C.-Y., Yuna Y.-J., Kimb J.-K., Leec J.M., Shind M., Songa D.-K., Hongb C.-W. Retinoic acid induces hypersegmentation and enhances cytotoxicityof neutrophils against cancer cells. Immunol. Lett., 2017, Vol. 182, pp. 24-29.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Skinner B.M., Johnson E.E. Nuclear morphologies: Their diversity and functional relevance. Chromosoma, 2017, Vol. 126, pp.195-212.</mixed-citation><mixed-citation xml:lang="en">Skinner B.M., Johnson E.E. Nuclear morphologies: Their diversity and functional relevance. Chromosoma, 2017, Vol. 126, pp.195-212.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Silva-Del Toro S.L., Allen L.-A.H. Microtubules and dynein regulate human neutrophil nuclear volume and hypersegmentation during H. pylori Infection. Front. Immunol., 2021, Vol. 12, 653100. doi: 10.3389/fimmu.2021.653100.</mixed-citation><mixed-citation xml:lang="en">Silva-Del Toro S.L., Allen L.-A.H. Microtubules and dynein regulate human neutrophil nuclear volume and hypersegmentation during H. pylori Infection. Front. Immunol., 2021, Vol. 12, 653100. doi: 10.3389/fimmu.2021.653100.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L., Huang Y., Zhou L., Dai Y., Hu G. High pretreatment neutrophil-tolymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck, 2019, Vol. 41, no. 5, pp. 1525-1535.</mixed-citation><mixed-citation xml:lang="en">Yang L., Huang Y., Zhou L., Dai Y., Hu G. High pretreatment neutrophil-tolymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck, 2019, Vol. 41, no. 5, pp. 1525-1535.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
